Lilly’s Mounjaro gives positive results in obese diabetic people
Mounjaro “is probably the best medicine other than insulin to treat diabetes,” says the lead author of a new study on Lilly’s drug.
By Nacha Cattan, Bloomberg
Eli Lilly & Co.’s diabetes drug Mounjaro significantly lowered blood sugar in people with the disease who were also obese, according to details from a study that raises the treatment’s profile in comparison to rivals.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
